*	OR T3 T4
R1	Subsumes Arg1:T7 Arg2:T8	
*	OR T6 T5
R2	Subsumes Arg1:T6 Arg2:T7	
R3	Subsumes Arg1:T11 Arg2:T12	
R4	Has_value Arg1:T11 Arg2:T13	
R5	Has_qualifier Arg1:T16 Arg2:T17	
R6	Has_value Arg1:T14 Arg2:T15	
*	OR T14 T16
T1	Drug 24 35	brentuximab
T2	Procedure 69 90	allogeneic transplant
T3	Condition 128 150	primary cutaneous ALCL
T4	Condition 191 196	sALCL
T5	Condition 228 245	meningeal disease
T6	Condition 219 227;238 245	cerebral disease
T7	Condition 277 319	progressive multifocal leukoencephalopathy
T8	Condition 321 324	PML
T10	Pregnancy_considerations 327 390	Female patients who are lactating and breastfeeding or pregnant
T11	Measurement 398 426	human immunodeficiency virus
T12	Measurement 428 431	HIV
T13	Value 433 441	positive
T14	Measurement 449 476	hepatitis B surface antigen
T15	Value 477 485	positive
T16	Condition 516 537	hepatitis C infection
T17	Qualifier 509 515	active
